Log in to save to my catalogue

Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis

Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11d5507fd1d34d12a76c1efedc616f2e

Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis

About this item

Full title

Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Advanced science, 2022-01, Vol.9 (1), p.e2104006-n/a

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Despite immunosuppression is critical for reducing immune overactivation, existing immunosuppressive agents are largely restricted by low inhibition efficiencies and unpredictable off‐target toxicities. Here, the use of the dopaminergic system is reported to suppress hyperactive immune responses in local inflamed tissues. A polydopamine nanoparticu...

Alternative Titles

Full title

Polydopamine Nanoparticle‐Mediated Dopaminergic Immunoregulation in Colitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_11d5507fd1d34d12a76c1efedc616f2e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11d5507fd1d34d12a76c1efedc616f2e

Other Identifiers

ISSN

2198-3844

E-ISSN

2198-3844

DOI

10.1002/advs.202104006

How to access this item